BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 26892129)

  • 1. Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis.
    Hussein H; Saheb S; Couturier M; Atassi M; Orsoni A; Carrié A; Therond P; Chantepie S; Robillard P; Bruckert E; Chapman MJ; Kontush A
    J Clin Lipidol; 2016; 10(1):124-33. PubMed ID: 26892129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities.
    Camont L; Lhomme M; Rached F; Le Goff W; Nègre-Salvayre A; Salvayre R; Calzada C; Lagarde M; Chapman MJ; Kontush A
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2715-23. PubMed ID: 24092747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidizability of atherogenic low-density lipoprotein subspecies in severe familial hypercholesterolemia: impact of long-term low-density lipoprotein apheresis.
    Lepage S; Nigon F; Bonnefont-Rousselot D; Assogba U; Goulinet S; Chancharme L; Delattre J; Bruckert E; Chapman MJ
    J Cardiovasc Pharmacol Ther; 2000 Apr; 5(2):87-103. PubMed ID: 11150388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis.
    Zerrad-Saadi A; Therond P; Chantepie S; Couturier M; Rye KA; Chapman MJ; Kontush A
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2169-75. PubMed ID: 19762782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities.
    Kontush A; Therond P; Zerrad A; Couturier M; Négre-Salvayre A; de Souza JA; Chantepie S; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1843-9. PubMed ID: 17569880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia.
    Nobécourt E; Jacqueminet S; Hansel B; Chantepie S; Grimaldi A; Chapman MJ; Kontush A
    Diabetologia; 2005 Mar; 48(3):529-38. PubMed ID: 15729582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity.
    de Souza JA; Vindis C; Hansel B; Nègre-Salvayre A; Therond P; Serrano CV; Chantepie S; Salvayre R; Bruckert E; Chapman MJ; Kontush A
    Atherosclerosis; 2008 Mar; 197(1):84-94. PubMed ID: 17868679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity.
    Hansel B; Giral P; Nobecourt E; Chantepie S; Bruckert E; Chapman MJ; Kontush A
    J Clin Endocrinol Metab; 2004 Oct; 89(10):4963-71. PubMed ID: 15472192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDL-apheresis depletes apoE-HDL and pre-β1-HDL in familial hypercholesterolemia: relevance to atheroprotection.
    Orsoni A; Saheb S; Levels JHM; Dallinga-Thie G; Atassi M; Bittar R; Robillard P; Bruckert E; Kontush A; Carrié A; Chapman MJ
    J Lipid Res; 2011 Dec; 52(12):2304-2313. PubMed ID: 21957200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities.
    Kontush A; Chapman MJ
    Curr Opin Lipidol; 2010 Aug; 21(4):312-8. PubMed ID: 20581677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer of lipids to high-density lipoprotein (HDL) is altered in patients with familial hypercholesterolemia.
    Martinez LR; Santos RD; Miname MH; Deus DF; Lima ES; Maranhão RC
    Metabolism; 2013 Aug; 62(8):1061-4. PubMed ID: 23540443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifestyle intervention enhances high-density lipoprotein function among patients with metabolic syndrome only at normal low-density lipoprotein cholesterol plasma levels.
    Hansel B; Bonnefont-Rousselot D; Orsoni A; Bittar R; Giral P; Roussel R; Marre M; Mohammedi K; Bruckert E; Chapman MJ; Kontush A
    J Clin Lipidol; 2016; 10(5):1172-81. PubMed ID: 27678434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonpharmacological lipoprotein apheresis reduces arterial inflammation in familial hypercholesterolemia.
    van Wijk DF; Sjouke B; Figueroa A; Emami H; van der Valk FM; MacNabb MH; Hemphill LC; Schulte DM; Koopman MG; Lobatto ME; Verberne HJ; Fayad ZA; Kastelein JJ; Mulder WJ; Hovingh GK; Tawakol A; Stroes ES
    J Am Coll Cardiol; 2014 Oct; 64(14):1418-26. PubMed ID: 25277610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure-lowering response to amlodipine as a determinant of the antioxidative activity of small, dense HDL3.
    Hansel B; Girerd X; Bonnefont-Rousselot D; Bittar R; Chantepie S; Orsoni A; Bruckert E; Chapman MJ; Kontush A
    Am J Cardiovasc Drugs; 2011 Oct; 11(5):317-25. PubMed ID: 21699274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties.
    Kontush A; de Faria EC; Chantepie S; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):526-33. PubMed ID: 14739123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atherosclerosis in familial hypercholesteremia possibly induced by defective HDL].
    Breier C; Lisch HJ; Drexel H; Braunsteiner H
    Schweiz Med Wochenschr; 1984 Mar; 114(9):288-91. PubMed ID: 6710113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis.
    Nenseter MS; Narverud I; Græsdal A; Bogsrud MP; Aukrust P; Retterstøl K; Ose L; Halvorsen B; Holven KB
    J Clin Lipidol; 2013; 7(2):109-16. PubMed ID: 23415429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered lipidome and antioxidative activity of small, dense HDL in normolipidemic rheumatoid arthritis: relevance of inflammation.
    Gómez Rosso L; Lhomme M; Meroño T; Sorroche P; Catoggio L; Soriano E; Saucedo C; Malah V; Dauteuille C; Boero L; Lesnik P; Robillard P; John Chapman M; Brites F; Kontush A
    Atherosclerosis; 2014 Dec; 237(2):652-60. PubMed ID: 25463101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: Relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A.
    Rached F; Lhomme M; Camont L; Gomes F; Dauteuille C; Robillard P; Santos RD; Lesnik P; Serrano CV; Chapman MJ; Kontush A
    Biochim Biophys Acta; 2015 Sep; 1851(9):1254-61. PubMed ID: 26037829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered composition of HDL3 in FH subjects causing a HDL subfraction with less atheroprotective function.
    Balstad TR; Holven KB; Ottestad IO; Otterdal K; Halvorsen B; Myhre AM; Ose L; Nenseter MS
    Clin Chim Acta; 2005 Sep; 359(1-2):171-8. PubMed ID: 15936009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.